Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.


Journal

Physiology & behavior
ISSN: 1873-507X
Titre abrégé: Physiol Behav
Pays: United States
ID NLM: 0151504

Informations de publication

Date de publication:
01 08 2022
Historique:
received: 24 02 2022
revised: 08 04 2022
accepted: 24 04 2022
pubmed: 30 4 2022
medline: 7 6 2022
entrez: 29 4 2022
Statut: ppublish

Résumé

It has been proposed that endogenous sex hormone levels may present a modifiable risk factor for cognitive decline. However, the evidence for effects of sex steroids on cognitive ageing is conflicting. We therefore investigated associations between endogenous hormone levels, androgen receptor CAG repeat length, and cognitive domains including visuoconstructional abilities, visual memory, and processing speed in a large-scale longitudinal study of middle-aged and older men. Men aged 40-79 years from the European Male Ageing Study (EMAS) underwent cognitive assessments and measurements of hormone levels at baseline and follow-up (mean = 4.4 years, SD ± 0.3 years). Hormone levels measured included total and calculated free testosterone and estradiol, dihydrotestosterone, luteinizing hormone, follicle-stimulating hormone, dehydroepiandrosterone sulphate and sex hormone-binding globulin. Cognitive function was assessed using the Rey-Osterrieth Complex Figure Copy and Recall, the Camden Topographical Recognition Memory and the Digit Symbol Substitution Test. Multivariate linear regressions were used to examine associations between baseline and change hormone levels, androgen receptor CAG repeat length, and cognitive decline. Statistical analyses included 1,827 and 1,423 participants for models investigating relationships of cognition with hormone levels and CAG repeat length, respectively. In age-adjusted models, we found a significant association of higher baseline free testosterone (β=-0.001, p=0.005) and dihydrotestosterone levels (β=-0.065, p=0.003) with greater decline on Rey-Osterrieth Complex Figure Recall over time. However, these effects were no longer significant following adjustment for centre, health, and lifestyle factors. No relationships were observed between any other baseline hormone levels, change in hormone levels, or androgen receptor CAG repeat length with cognitive decline in the measured domains. In this large-scale prospective study there was no evidence for an association between endogenous sex hormone levels or CAG repeat length and cognitive ageing in men. These data suggest that sex steroid levels do not affect visuospatial function, visual memory, or processing speed in middle-aged and older men.

Identifiants

pubmed: 35487276
pii: S0031-9384(22)00131-7
doi: 10.1016/j.physbeh.2022.113825
pii:
doi:

Substances chimiques

Receptors, Androgen 0
Dihydrotestosterone 08J2K08A3Y
Testosterone 3XMK78S47O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113825

Subventions

Organisme : Versus Arthritis
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Margot J Overman (MJ)

Gerontology and Geriatrics, KU Leuven, Leuven, Belgium; Department of Psychiatry, University of Oxford, UK.

Neil Pendleton (N)

Clinical & Cognitive Neurosciences, Institute of Brain, Behaviour and Mental Health, The University of Manchester, UK.

Terence W O'Neill (TW)

Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.

Gyorgy Bartfai (G)

Department of Obstetrics, Gynaecology and Andrology, Albert Szent-György Medical University, Szeged, Hungary.

Felipe F Casanueva (FF)

Department of Medicine, Santiago de Compostela University Spain; CIBEROBN Instituto de Salud Carlos III. Santiago de Compostela, Spain.

Gianni Forti (G)

Endocrinology Unit, University of Florence, Florence, Italy.

Giulia Rastrelli (G)

Sexual Medicine and Andrology Unit, Department of Experimental, Clinical, and Biomedical Sciences, University of Florence, Florence, Italy.

Aleksander Giwercman (A)

Reproductive Medicine Centre, Skåne University Hospital, University of Lund, Lund, Sweden.

Thang S Han (TS)

Institute of Cardiovascular Research, Royal Holloway University of London, Egham, Surrey, UK.

Ilpo T Huhtaniemi (IT)

Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Campus, London UK.

Jolanta Slowikowska-Hilczer (J)

Department of Andrology and Reproductive Endocrinology, Medical University of Łódź, Łódź, Poland.

Michael Ej Lean (ME)

Department of Human Nutrition, University of Glasgow, Glasgow, UK.

Margus Punab (M)

Andrology Unit, Tartu University Hospital, Tartu, Estonia.

David M Lee (DM)

Faculty of Health, Psychology and Social Care, Manchester Metropolitan University, Manchester, UK.

Leen Antonio (L)

Department of Andrology and Endocrinology, KU Leuven, Leuven, Belgium; Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.

Evelien Gielen (E)

Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Martin K Rutter (MK)

Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Medical and Human Sciences, Institute of Human Development, University of Manchester, Manchester, UK; Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Dirk Vanderschueren (D)

Department of Andrology and Endocrinology, KU Leuven, Leuven, Belgium; Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.

Frederick Cw Wu (FC)

Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Medical and Human Sciences, Institute of Human Development, University of Manchester, Manchester, UK.

Jos Tournoy (J)

Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium. Electronic address: jos.tournoy@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH